Preliminary Study: Expulsive Effect of Empagliflozin on Small Lower Ureteric Stones in Type II Diabetic Patients
Background and aim Currently, a new oral diabetes medication comprises inhibition of the sodium-glucose co-transporter 2 (SGLT2), resulting in glycosuria, which may have a dislodging impact on stone ureter. The purpose of this trial was to examine and compare efficacy of empagliflozin in treatment o...
Saved in:
Main Authors: | Alsayed S. Abdelaziz, Mohab AS. Abdalaziz, Mostafa M. Ebraheem, Ali A. Raheem, Ayman M. Ghoneem |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
Series: | Al-Azhar Assiut Medical Journal |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/azmj.azmj_53_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhancing stone expulsion: The efficacy of combined medical therapy with tamsulosin and dexamethasone in renal colic patients
by: Reza Kazemi, et al.
Published: (2025-01-01) -
Clinical outcomes of intravenous urography-assisted shockwave lithotripsy for radiolucent ureteral stones
by: Shinya Somiya, et al.
Published: (2025-01-01) -
The Association of SGLT-2 inhibitors (Empagliflozin) with the development of hypernatremic dehydration: a case report
by: Diana Alegre-González, et al.
Published: (2025-10-01) -
Kidney stone characteristics in diabetics versus nondiabetics at a tertiary care center in Saudi Arabia
by: Ibrahim Basem Nafadi, et al.
Published: (2025-01-01) -
Which combination of medical expulsive therapy is more effective for treatment of distal ureteral stone in adults? A systematic review and network meta-analysis
by: Maryam Taheri, et al.
Published: (2025-01-01)